SC
NVCR icon

Steven Cohen’s NovoCure NVCR Stock Holding History

Steven Cohen’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,000
Closed -$623K – 2754
2023
Q2 		$623K Buy
+15,000
New +$931K ﹤0.01% 1223
2023
Q1 		– Sell
-155,000
Closed -$11.4M – 2453
2022
Q4 		$11.4M Buy
+155,000
New +$11.7M 0.04% 509

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Steven Cohen's NVCR Position: Q2 2026 in Review

Steven Cohen reduced its NovoCure (NVCR) stake by 41% in Q2 2026, selling an estimated $8.45M and leaving 803,120 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #1172.

Steven Cohen first reported a position in NVCR in Q1 2019 and has held it in 11 quarters since. The position peaked at $14.8M in Q1 2026. 215 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Steven Cohen held 803,120 shares of NovoCure worth $12.2M as of Q2 2026.
  • Steven Cohen sold 558,271 NovoCure shares in Q2 2026, an estimated $8.45M.
  • NovoCure made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1172 holding.
  • Steven Cohen first reported a position in NovoCure in Q1 2019 and has held it in 11 quarters since.
  • Steven Cohen's NovoCure position peaked at $14.8M in Q1 2026.
  • 215 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.